Voip-Pal.com, Inc. (OTCMKTS:VPLM) Continues Climb, Though Slower
The stock of Voip-Pal.com, Inc. (OTCMKTS:VPLM) is gasping for air at its relatively high peak, as it managed to hold onto gains on Monday and open higher on Tuesday. VPLM is rising without a new promotion, adding more than 15% at the beginning of the new week. Dollar volumes were $1.19 million. There has not been a new PR message since September 26th, and VPLM seems to be rising on momentum, not stopping as the markets opened cheerfully despite the news of the US Federal Government remaining in shutdown.
But despite the cheer, and even the expectations that VPLM could resolve Europe’s problems with pricy cross-border calls, VPLM remains weak financially, a certain indicator that a drop in price could be justified. Added to this, the stock is at a three-year peak, and might just need to backtrack a bit.
Still, at 16 cents VPLM may be accessible enough to continue the run for a while. VPLM has another asset- it’s working on a “Lawful intercept” technology, having defended a patent. So far, no one else has shown such a patent for intercepting calls and messages. But the question remains if VPLM will be able to sell that technology, especially as society becomes more aware of tracking scandals.
But the company sends shaky quarterly reports, and despite its patents, has all the signs of a disproportionately inflated pink sheet. VPLM remains a selection with too many red flags, and we are expecting a deep correction soon.
ImageWare Systems, Inc. (OTCMKTS:IWSY) was just as promising in August, but went on to slide from its peak above $3, stopped for a while around $2 and has been deflating in the past days, further toward $1.50. The company is one with a stronger financial back and a promising business model, but this has not yet caused a stock recovery.
Another hot technology belongs to Sigma Labs, Inc. (OTCMKTS:SGLB), a 3D printing company. SGLB is hanging around the 10-cent levels, after peaking at around 12 cents. The stock will have to show if it has enough power to continue without a regular infusion of good news. Still, SGLB shows longer- term potential, and is steadier than VPLM.